132 related articles for article (PubMed ID: 6183699)
1. Interferon: pharmacokinetics and toxicity.
Scott GM
Philos Trans R Soc Lond B Biol Sci; 1982 Sep; 299(1094):91-107. PubMed ID: 6183699
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and side effects of interferon in man.
Merigan TC
Tex Rep Biol Med; 1977; 35():541-7. PubMed ID: 358475
[No Abstract] [Full Text] [Related]
3. Toxicity of interferon.
Scott GM; Secher DS; Flowers D; Bate J; Cantell K; Tyrrell DA
Br Med J (Clin Res Ed); 1981 Apr; 282(6273):1345-8. PubMed ID: 6165428
[TBL] [Abstract][Full Text] [Related]
4. [Interferons--its method of administration and adverse effect related to pharmacokinetics ].
Furue H
Gan To Kagaku Ryoho; 1984 Feb; 11(2):186-93. PubMed ID: 6582804
[TBL] [Abstract][Full Text] [Related]
5. Prevention of vaccinia lesions in Rhesus monkeys by human leucocyte and fibroblast interferon.
Weimar W; Stitz L; Billiau A; Cantell K; Schellekens H
J Gen Virol; 1980 May; 48(1):25-30. PubMed ID: 6155433
[TBL] [Abstract][Full Text] [Related]
6. Neutralizing antibodies against human leukocyte, lymphoblastoid and fibroblast interferons elicited by immunization with human leukocyte interferon.
Pyhälä
Acta Pathol Microbiol Scand C; 1978 Dec; 86C(6):291-8. PubMed ID: 726897
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of routes of administration of interferon in cancer: a review and a proposal.
Bocci V
Cancer Drug Deliv; 1984; 1(4):337-51. PubMed ID: 6085757
[TBL] [Abstract][Full Text] [Related]
8. Human lymphoblastoid cells as a source of interferon.
Finter NB; Fantes KH; Johnston M
Dev Biol Stand; 1977 Apr 13-15; 38():343-8. PubMed ID: 608522
[TBL] [Abstract][Full Text] [Related]
9. Interferon: mechanisms of action and clinical value.
Houglum JE
Clin Pharm; 1983; 2(1):20-8. PubMed ID: 6192965
[TBL] [Abstract][Full Text] [Related]
10. The pharmacology and toxicology of the interferons: an overview.
Mannering GJ; Deloria LB
Annu Rev Pharmacol Toxicol; 1986; 26():455-515. PubMed ID: 2424363
[TBL] [Abstract][Full Text] [Related]
11. Tissue distribution of human interferons after exogenous administration in rabbits, monkeys, and mice.
Billiau A; Heremans H; Ververken D; van Damme J; Carton H; de Somer P
Arch Virol; 1981; 68(1):19-25. PubMed ID: 6166278
[TBL] [Abstract][Full Text] [Related]
12. Biological properties of virus-induced interferons.
Burke DC
Tex Rep Biol Med; 1977; 35():11-6. PubMed ID: 80828
[TBL] [Abstract][Full Text] [Related]
13. [Distribution of human interferon in organs and tissues after its administration to man and animals].
Maiakova SA; Berulava II; Gavrilova IE; Kuznetsov VP
Vopr Virusol; 1980; (5):594-6. PubMed ID: 6159738
[TBL] [Abstract][Full Text] [Related]
14. Circulating interferon in man after administration of exogenous human leukocyte interferon.
Emödi G; Just M; Hernandez R; Hirt HR
J Natl Cancer Inst; 1975 May; 54(5):1045-9. PubMed ID: 1127735
[TBL] [Abstract][Full Text] [Related]
15. Preliminary observations on the pharmacokinetics of human lymphoblastoid interferon given by intramuscular injection.
Priestman TJ; Johnston M; Whiteman PD
Clin Oncol; 1982; 8(3):265-9. PubMed ID: 6183041
[No Abstract] [Full Text] [Related]
16. Human fibroblast interferon for clinical trials: pharmacokinetics and tolerability in experimental animals and humans.
Billiau A; De Somers P; Edy VG; De Clercq E; Heremans H
Antimicrob Agents Chemother; 1979 Jul; 16(1):56-63. PubMed ID: 475375
[TBL] [Abstract][Full Text] [Related]
17. Interferon enhancement of the invasive capacity of Ewing sarcoma cells in vitro.
Siegal GP; Thorgeirsson UP; Russo RG; Wallace DM; Liotta LA; Berger SL
Proc Natl Acad Sci U S A; 1982 Jul; 79(13):4064-8. PubMed ID: 6180434
[TBL] [Abstract][Full Text] [Related]
18. Novel interferons for treatment of hepatitis C virus.
Clark V; Nelson DR
Clin Liver Dis; 2009 Aug; 13(3):351-63. PubMed ID: 19628153
[TBL] [Abstract][Full Text] [Related]
19. Influence of interferon preparations on the proliferative capacity of human and mouse bone marrow cells in vitro.
van 't Hull E; Schellekens H; Löwenberg B; de Vries MJ
Cancer Res; 1978 Apr; 38(4):911-4. PubMed ID: 639045
[TBL] [Abstract][Full Text] [Related]
20. Tolerability of pure fibroblast interferon in man.
Billiau A; Heine JW; Van Damme J; Heremans H; De Somer P
Ann N Y Acad Sci; 1980; 350():374-5. PubMed ID: 6165288
[No Abstract] [Full Text] [Related]
[Next] [New Search]
